Article ; Online: Tocilizumab for reduction of mortality in severe COVID-19 patients: How should we GRADE it?
British journal of clinical pharmacology
2022 Volume 88, Issue 7, Page(s) 3539–3541
MeSH term(s) | Antibodies, Monoclonal, Humanized/therapeutic use ; COVID-19/drug therapy ; Humans ; SARS-CoV-2 ; Treatment Outcome |
---|---|
Chemical Substances | Antibodies, Monoclonal, Humanized ; tocilizumab (I031V2H011) |
Language | English |
Publishing date | 2022-03-02 |
Publishing country | England |
Document type | Letter |
ZDB-ID | 188974-6 |
ISSN | 1365-2125 ; 0306-5251 ; 0264-3774 |
ISSN (online) | 1365-2125 |
ISSN | 0306-5251 ; 0264-3774 |
DOI | 10.1111/bcp.15283 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 1118: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.